Belluscura PLC - London-headquartered medical device developer - After announcing in January the revised terms of an all-share offer by Belluscura for the whole of the issued share capital of TMT Acquisition PLC, Belluscura says that the full terms and conditions have now been satisfied or waived. This is apart from a final condition, which is for the admission of new Belluscura shares to be issued in respect of the offer to trading on AIM. Adds that the offer remains open for acceptances, and TMT Acquisition shareholders who have not yet accepted the offer ‘are urged to do so as soon as possible’.

Current stock price: 19.00 pence

12-month change: down 57%

Copyright 2024 Alliance News Ltd. All Rights Reserved.